Justin Stebbing, Professor of Cancer Medicine and Oncology at Imperial College, shared an article on LinkedIn:
“I wrote this editorial with the fantastic Andrea Bullock from Harvard on CD47, a fascinating immunotherapy target but very much work in progress.”
CD47 as a potential predictive biomarker in colorectal cancer.
Authors: Justin Stebbing and Andrea Bullock
